SCHEMBL18656107

SCHEMBL18656107

[N-]=[N+]=NCCNCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13992018 0.87
SCHEMBL16587955 0.86 IDUA (0.30)
SCHEMBL28766375 0.84 IDUA (0.33)
SCHEMBL25756358 0.79 TSHR (0.36)
SCHEMBL25756224 0.79 TSHR (0.39)
SCHEMBL23765754 0.78 MEN1 (0.41)
SCHEMBL19872804 0.77
SCHEMBL17318111 0.76 CA2 (0.32)
SCHEMBL16587606 0.75
SCHEMBL25457443 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022112855-A1 LIPID COMPOUND AND THE COMPOSITION THEREOF Guangzhou Ribobio Co., Ltd (CN) 2022-06-02 WO disclosed
US-11141495-B2 MRI imaging of amyloid plaque using liposomes TEXAS CHILDREN'S HOSPITAL (US) 2021-10-12 US disclosed
US-9744251-B2 MRI imaging of amyloid plaque using liposomes Alzeca Biosciences, LLC 2017-08-29 US disclosed
US-20170080111-A1 MRI IMAGING OF AMYLOID PLAQUE USING LIPOSOMES Alzeca Biosciences, LLC 2017-03-23 US disclosed